Crossmark

Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence

Crossref DOI link: https://doi.org/10.1007/s00125-019-4841-1

Published Online: 2019-02-27

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Skog, Oskar https://orcid.org/0000-0001-9713-722X
Klingel, Karin

Roivainen, Merja

Korsgren, Olle
Funding

Funding for this research was provided by:

The Sten A Olsson foundation

Åke Wiberg Stiftelse

Stiftelsen Familjen Ernfors Fond

Diabetes Research & Wellness Foundation

Vetenskapsrådet (K2015-54X-12219-19-4)

Diabetesfonden

Juvenile Diabetes Research Foundation International

Novo Nordisk UK Research Foundation

Barndiabetesfonden

Tore Nilsons Stiftelse för Medicinsk Forskning

Leona M. and Harry B. Helmsley Charitable Trust
License Information

Text and Data Mining valid from 2019-02-27
More Information

Article History

Received: 6 February 2019

Accepted: 8 February 2019

First Online: 27 February 2019

Duality of interest

: The authors declare that there is no duality of interest associated with this manuscript.